[HTML][HTML] MicroRNAs as potential biomarkers for diagnosis of major depressive disorder and influence of antidepressant treatment

B Martinez, PV Peplow - NeuroMarkers, 2024 - Elsevier
We performed a PubMed search for microRNA biomarkers in major depressive disorder
(MDD) and found 25 original research articles on studies performed with human patients …

The role of ncRNAs in depression

X Luan, H Xing, F Guo, W Liu, Y Jiao, Z Liu, X Wang… - Heliyon, 2024 - cell.com
Depressive disorders have a significant impact on public health, and depression have an
unsatisfactory recurrence rate and are challenging to treat. Non-coding RNAs (ncRNAs) are …

Peripheral blood miRNA expression in patients with essential hypertension in the Han Chinese population in Hefei, China

B Cheng, R Yang, H Xu, L Wang, N Jiang, T Song… - Biochemical …, 2024 - Springer
Primary hypertension is a significant risk factor for cardiovascular diseases. However, the
pathogenesis of primary hypertension involves multiple biological processes, including the …

[HTML][HTML] Misdiagnoses of psychiatric disorders and the utility of diagnostic microRNA biomarkers

B Martinez, PV Peplow - NeuroMarkers, 2024 - Elsevier
Due to overlapping symptoms and similarities with other illnesses, misdiagnosis and
inappropriate treatment of psychiatric disorders frequently occur. Objective laboratory-based …

[PDF][PDF] History of Micrornas: From Gene Controlling Development of Nematodes to a Promising Tool for Molecular Therapy

B Dusan - Acta Medica Martiniana, 2024 - sciendo.com
A bstract MicroRNAs are short, single-stranded RNA molecules that typically consist of a 22-
nucleotide sequence. Despite their small size, these molecules play an essential role in …

[HTML][HTML] From microRNA to protein, linking the neurotrophic hypothesis of depression to the Wistar Kyoto rat

E Kaadt, NK Hedemann, CK Damgaard, HK Müller… - Neuroscience …, 2023 - Elsevier
Animal models of depression offer an alternative research-platform to clinical studies where
limitations such as incomplete medical histories, patient heterogeneity, and difficulty tracking …